DEA Schedules 7-OH: What It Means For Natural Kratom
The two Notices of Intent, the 0.05% / 1 mg threshold, the timeline to effect, and what our COAs show.
Legality & Advocacy Hub
The current legal status of kratom (Mitragyna speciosa) in all 50 states and Washington, D.C. — maintained and updated by the Kraken Kratom team as laws change. Statute citations, effective dates, the federal 7-OH scheduling timeline, and a watch list of pending 2026 legislation.
As of July 3, 2026, kratom is legal under U.S. federal law. Ten states ban it, 17 states regulate it under KCPA-style frameworks, 3 restrict it in part, 4 face major pending legislation, and 17 have no kratom-specific law.
At a Glance
State kratom law runs on five tracks: outright prohibition, KCPA-style regulation, partial restriction, pending major legislation, and no law at all. Regulation remains the largest and fastest-growing lane.
10
States ban kratom outright
AL, AR, CT, IN, KS, LA, ND, TN, VT, WI. Kansas and Tennessee are the newest — both bans effective July 1, 2026.
17
States regulate kratom (KCPA-style)
Utah passed the first KCPA in 2019; 17 states now run KCPA-style frameworks. Another 3 restrict kratom in part (Florida, Ohio, Washington), 4 face major pending legislation, and 17 have no kratom-specific law.
4+fed
Jurisdictions with major legislation pending
Four states have active bills that would ban or reclassify kratom — plus the federal DEA 7-OH scheduling action now in its comment period. Track every open bill and docket ↓
1st
Ban reversal in U.S. history
Rhode Island banned kratom in 2017 and reversed course effective April 1, 2026, replacing prohibition with a KCPA-style regulated framework — the first state ever to do so.
Federal Status
Kratom is not a federally controlled substance. The DEA proposed scheduling it in 2016 and withdrew the proposal after public and congressional pushback. Since then, federal activity has focused not on the kratom leaf itself but on concentrated and synthetic 7-hydroxymitragynine (7-OH) products — a category chemically and commercially distinct from traditional leaf kratom.
July 1, 2026 — DEA files intent to schedule concentrated 7-OH. The DEA filed two Notices of Intent with the Federal Register to temporarily place 7-OH above a specified threshold — 0.05% of dry weight, or more than 1 mg per product unit — plus three related substances (mitragynine pseudoindoxyl, MGM-15, MGM-16) into Schedule I. Formal publication is set for July 6, 2026; the temporary order takes effect 30 days later and lasts up to two years, extendable by one. The action does not apply to botanical kratom products containing naturally occurring 7-OH below the threshold.
Every Kraken Kratom product is third-party lab tested, and current certificates of analysis confirm 7-OH content below the DEA's specified threshold across our full catalog — including extracts, shots, and tablets. Our products contain naturally occurring alkaloids from the kratom leaf; we do not sell synthetically enhanced or 7-OH concentrated products.
HHS opened a 30-day public comment period on the proposed threshold (comments due July 31, 2026). The threshold — not the Schedule I classification itself — is the open question. We're tracking the docket and will update this page and the changelog when the temporary order publishes and when it takes effect in early August.
State by State
Statuses verified July 2, 2026 by the Kraken Kratom team. Hover, tap, or focus a state on the map for its status and recent developments — or expand the full text table below. The same dataset drives both.
📍 Hover, tap, or focus a state to see its kratom legal status and recent developments.
| Jurisdiction | Status | Framework & notes |
|---|---|---|
| Alabama | Banned | Banned since 2016. Alkaloids classified Schedule I. |
| Alaska | Legal | No statewide law. Proposed Anchorage ban pending. |
| Arizona | Regulated | KCPA in effect. Age: 18+. |
| Arkansas | Banned | Full statewide prohibition. |
| California | Legal | No statewide kratom law. Local bans in San Diego, Oceanside & Newport Beach; CDPH retail enforcement active. |
| Colorado | Regulated | KCPA. Denver has a local ban. Synthetic 7-OH prohibited. Age: 18+. |
| Connecticut | Banned | Schedule I designation (HB6855). Enforcement began Feb 2026. |
| Delaware | Legal | No specific restrictions. |
| Florida | Restricted | Legal statewide except Sarasota County ban. Concentrated 7-OH products restricted. |
| Georgia | Regulated | KCPA. Age raised to 21+ in Jan 2025. Age: 21+. |
| Hawaii | Pending | Currently legal. Ban legislation under consideration. |
| Idaho | Legal | Legal. KCPA bill (SB 1282) stalled in committee. |
| Illinois | Regulated | KCPA in effect. Age: 18+. |
| Indiana | Banned | Banned since 2014. |
| Iowa | Pending | Currently legal. SF 2013 proposes Schedule I classification. Age: 18+. |
| Kansas | Banned | Schedule I ban (HB 2365). 7-OH scheduled with no threshold, so all kratom is banned. Effective July 1, 2026. |
| Kentucky | Regulated | Legal with KCPA-style regulation. |
| Louisiana | Banned | Ban effective Aug 2025 (SB 154). Penalties up to 5 years. We cannot ship here. |
| Maine | Legal | No statewide restrictions. |
| Maryland | Regulated | KCPA passed and signed 2024. |
| Massachusetts | Pending | Currently legal. Competing KCPA & ban bills filed 2025. |
| Michigan | Pending | Currently legal. HB 5537 would prohibit kratom. |
| Minnesota | Regulated | Legal 18+. KCPA review pending. Age: 18+. |
| Mississippi | Regulated | KCPA (HB1077) effective Jul 2025. Bans synthetic 7-OH. Age: 21+. |
| Missouri | Legal | Legal. Regulations under review. |
| Montana | Legal | No specific regulation. |
| Nebraska | Legal | No specific regulation. |
| Nevada | Regulated | KCPA passed. |
| New Hampshire | Legal | Legal 18+. Some local variations. Age: 18+. |
| New Jersey | Legal | No specific kratom regulation. |
| New Mexico | Legal | No specific regulation. |
| New York | Regulated | 21+ sales restriction implemented 2025. Age: 21+. |
| North Carolina | Legal | Legal. 18+ age practice widely followed. Age: 18+. |
| North Dakota | Banned | Full statewide prohibition. |
| Ohio | Restricted | Emergency rule (Dec 2025) bans most products except pure mitragynine. |
| Oklahoma | Regulated | KCPA regulation established. |
| Oregon | Regulated | 21+ age requirement. Kratom must be disclosed as an ingredient. Age: 21+. |
| Pennsylvania | Legal | No specific kratom regulation. |
| Rhode Island | Regulated | Ban REVERSED — regulated framework live as of Apr 1, 2026 (first state to reverse a ban). Age: 21+. |
| South Carolina | Regulated | KCPA signed May 2025. Locked display cases required. |
| South Dakota | Legal | Legal 21+. Ban attempt failed Jan 2026. Age: 21+. |
| Tennessee | Banned | NEW BAN — “Matthew Davenport’s Law” (HB1649) signed; full ban effective July 1, 2026. |
| Texas | Legal | Legal. HSC Ch. 444 caps 7-OH at 2% of alkaloids and bans synthetic alkaloids. Bills pending. |
| Utah | Regulated | KCPA in place. SB 45 amended — plain leaf remains legal. |
| Vermont | Banned | Complete statewide ban. |
| Virginia | Regulated | KCPA passed 2023. |
| Washington | Restricted | Legal except the Spokane city ban (Mar 2026). 95% excise tax proposed. |
| West Virginia | Regulated | KCPA passed 2023. |
| Wisconsin | Banned | Statewide prohibition. |
| Wyoming | Legal | No specific regulation. Ban attempt defeated 2026. |
| District of Columbia | Legal | No specific regulation. |
Local ordinances matter. Even where kratom is legal statewide, cities and counties can restrict it — Denver (CO); San Diego, Oceanside & Newport Beach (CA); Sarasota County (FL); and Spokane (WA), among others. Always verify local law before purchasing or traveling with kratom products.
Timeline
Thirty days after formal Federal Register publication, Schedule I controls apply to 7-OH above the specified threshold and to MP, MGM-15, and MGM-16. Effective for two years, extendable by one.
The 30-day comment window addresses whether the 0.05% dry-weight / 1 mg-per-unit threshold is appropriate — not whether scheduling occurs.
Formal publication of both Notices of Intent starts the 30-day clock to the temporary scheduling order.
The DEA files two Notices of Intent to temporarily place 7-OH above a 0.05% dry-weight / 1 mg-per-unit threshold, plus three related substances, into Schedule I. Botanical kratom below the threshold is explicitly excluded. Our full analysis.
Kansas’s ban takes effect, making it the 9th state to fully ban kratom. Signed by Gov. Laura Kelly in April 2026, HB 2365 adds 7-OH and kratom-related substances to Schedule I — and because 7-OH occurs naturally in all kratom leaf with no concentration threshold, it prohibits every kratom product.
Tennessee’s full statewide ban takes effect — covering natural leaf, powder, capsules, and extracts — making it the 8th state to fully ban kratom. The law, “Matthew Davenport’s Law” (HB1649), was signed by Gov. Bill Lee in April 2026.
The Rhode Island Kratom Act took effect, formally moving the state from prohibition to a KCPA-style regulated market for adults 21+.
Spokane enacted a local ban on kratom sales — a reminder that even in legal states, local jurisdictions can impose their own restrictions.
Ohio’s Board of Pharmacy issued an emergency rule banning most kratom products except those composed solely of pure mitragynine.
Louisiana’s SB 154 went into effect, making it the 6th state to fully prohibit kratom, with penalties up to 5 years. Kraken Kratom can no longer ship to Louisiana.
Federal health officials recommended scheduling synthetic 7-hydroxymitragynine. This targets synthetic derivatives — not natural kratom leaf — and the DEA has not finalized a rule, but it accelerated state-level action on 7-OH products.
In a historic first, Rhode Island passed legislation to reverse its kratom ban and move to a regulated framework — the first state ever to reverse a kratom prohibition.
Connecticut designated kratom and its derivatives, including 7-OH, as Schedule I substances. Enforcement began in February 2026.
South Carolina’s KCPA took effect, requiring locked display cases and setting limits on synthetic alkaloid content — a model for responsible regulation.
Mississippi adopted the Kratom Consumer Protection Act, setting a 21+ age requirement and banning synthetic 7-OH concentrates while keeping natural kratom accessible to adults.
Earlier history — the 2016 DEA withdrawal, the first KCPA (Utah, 2019), the WHO's 2021 review decision — is covered in our legality archive.
Legislative Watch
Every measure below is live — statuses are re-verified as legislatures and agencies act, and each change is recorded in the changelog. Rows show the date they were last verified, so you always know how current the information is.
| Action | What it does | Status & last action | What's next |
|---|---|---|---|
| DEA — 7-OH scheduling (NOI 1) | Temporarily places 7-hydroxymitragynine above 0.05% dry weight, or >1 mg per unit, into Schedule I for two years. Botanical kratom below the threshold is excluded. | Notice of Intent filed July 1, 2026. | Federal Register publication July 6; effective 30 days later (~early August 2026). |
| DEA — related substances (NOI 2) | Same temporary Schedule I placement for mitragynine pseudoindoxyl, MGM-15, and MGM-16. | Notice of Intent filed July 1, 2026. | Same timeline as NOI 1. |
| HHS — threshold comment period | Public comment on whether the 0.05% / 1 mg threshold is set appropriately (Docket HHS-OASH-2026-0232). | Comment window open. | Comments due July 31, 2026. |
| State | Measure | What it does | Status & last action | What's next |
|---|---|---|---|---|
| Michigan | HB 5537 | Statewide kratom ban. | Passed the House; pending in the Senate. | Senate committee action. Kratom remains legal while pending. |
| New Hampshire | KCPA bill | Kratom Consumer Protection Act — age, labeling, and testing framework. | Passed the Senate. | Awaiting House action. |
| Iowa | SF 2013 | Would place kratom alkaloids in Schedule I. | Introduced; in committee. | Committee hearing schedule. |
| Hawaii | Ban legislation | Would prohibit kratom sale and possession statewide. | Pending. | Committee action. |
How this tracker works. When a bill moves or a federal docket updates, we update its row, the state's map status if the law changes, and the changelog — usually within days. If a row's verified date looks stale during an active session, tell us.
Latest From Kraken
Our analysis and updates as the law changes. New posts are added here when they publish.
The two Notices of Intent, the 0.05% / 1 mg threshold, the timeline to effect, and what our COAs show.
What the two newest state bans cover, effective dates, and penalty structures.
The HHS/FDA recommendation on concentrated 7-OH products — the action that set up the DEA's July 2026 scheduling notices.
For Media & Researchers
Journalists, researchers, and policy analysts are welcome to cite this tracker with attribution and a link. Suggested citation: "Kratom Legality & Advocacy Hub, Kraken Kratom, verified July 3, 2026." Every status change is recorded in the dated changelog below, so historical statuses can be reconstructed.
Kraken Kratom supports consumer-protection regulation over prohibition. Accurate, current legal information serves consumers, retailers, and policymakers alike — and most published kratom legality maps are months out of date. For interview requests or data questions, contact our team.
FAQ
Kratom (Mitragyna speciosa) is legal under U.S. federal law — it is not a federally controlled substance. Regulation happens primarily at the state level: as of July 2026, ten states ban kratom, 17 states regulate it under Kratom Consumer Protection Act (KCPA) style frameworks, 3 restrict it in part, 4 face major pending legislation, and 17 have no kratom-specific law. Some cities and counties in otherwise-legal states have local restrictions.
As of July 2026, ten states ban kratom: Alabama, Arkansas, Connecticut, Indiana, Kansas, Louisiana, North Dakota, Tennessee, Vermont, and Wisconsin. The Kansas and Tennessee bans both took effect July 1, 2026. Rhode Island, which banned kratom in 2017, reversed its ban effective April 1, 2026 — the first state ever to do so.
The KCPA is model legislation developed by the American Kratom Association that regulates kratom rather than banning it. KCPA laws typically require minimum purchase ages (usually 21+), accurate alkaloid labeling, third-party laboratory testing for contaminants, and prohibit adulterated or synthetic products. Utah passed the first KCPA in 2019, and a growing number of states have adopted KCPA-style frameworks since.
On July 1, 2026, the DEA filed two Notices of Intent to temporarily place 7-hydroxymitragynine (7-OH) above a specified concentration threshold — 0.05% of dry weight, or more than 1 milligram per product unit — plus three related substances (mitragynine pseudoindoxyl, MGM-15, and MGM-16) into Schedule I of the Controlled Substances Act.
The action targets concentrated and synthetic 7-OH products. It does not apply to botanical kratom products containing naturally occurring 7-OH below the threshold. The temporary scheduling takes effect 30 days after formal Federal Register publication on July 6, 2026, and lasts up to two years with a possible one-year extension.
Every Kraken Kratom product — including extracts, shots, and tablets — is third-party lab tested, and current certificates of analysis confirm 7-OH content below the DEA's specified threshold. Kraken products contain naturally occurring alkaloids from the kratom leaf; we do not sell synthetically enhanced or 7-OH concentrated products. Full lab results are available on our lab testing page.
This hub is maintained as a living resource. State statuses, the federal timeline, and the legislative watch list are reviewed and updated when laws change, with each revision recorded in the dated changelog at the bottom of the page.
Changelog
Sources
Every Kraken product ships with third-party lab testing and full COA access. We ship to all states where kratom is legal.
This page is educational and informational only and is not legal advice. Laws change frequently; consult an attorney licensed in your jurisdiction for legal questions. Kraken Kratom products are not intended to diagnose, treat, cure, or prevent any disease.